XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Deferred Compensation Employee Stock Trust, Net
Employee Stock Trust
Noncontrolling Interest
Total
Balance at Dec. 31, 2020 $ 2,323,939 $ 822 $ 1,317,929 $ 17,763 $ 986,792 $ 771 $ (138) $ 26,708 $ 2,350,647
Balance (in shares) at Dec. 31, 2020   82,185         7    
Increase (Decrease) in Stockholders' Equity                  
Net income 219,404       219,404     6,473 225,877
Other comprehensive income (loss) (10,670)     (10,670)         (10,670)
Stock-based compensation expense 8,786   8,786           8,786
Common stock issued to board members 297   297           297
Common stock issued to board members (in shares)   8              
Issuance of common stock related to share-based awards, net (2,250) $ 3 (2,253)           (2,250)
Issuance of common stock related to share-based awards, net (in shares)   351              
Repurchases of common stock (49,471) $ (13) (22,320)   (27,138)       (49,471)
Repurchases of common stock (in shares)   (1,391)              
Dividends on common stock (19,754)       (19,754)       (19,754)
Deferred compensation plan           (17) $ 17    
Deferred compensation plan (in shares)             (1)    
Net cash distributed to noncontrolling interest               (7,086) (7,086)
Balance at Jun. 30, 2021 2,470,281 $ 812 1,302,439 7,093 1,159,304 754 $ (121) 26,095 2,496,376
Balance (in shares) at Jun. 30, 2021   81,153         6    
Balance at Mar. 31, 2021 2,419,185 $ 823 1,319,518 3,486 1,094,727 752 $ (121) 26,830 2,446,015
Balance (in shares) at Mar. 31, 2021   82,261         6    
Increase (Decrease) in Stockholders' Equity                  
Net income 99,060       99,060     2,873 101,933
Other comprehensive income (loss) 3,607     3,607         3,607
Stock-based compensation expense 4,192   4,192           4,192
Common stock issued to board members 150   150           150
Common stock issued to board members (in shares)   4              
Issuance of common stock related to share-based awards, net (1,504) $ 1 (1,505)           (1,504)
Issuance of common stock related to share-based awards, net (in shares)   129              
Repurchases of common stock (44,522) $ (12) (19,916)   (24,594)       (44,522)
Repurchases of common stock (in shares)   (1,241)              
Dividends on common stock (9,889)       (9,889)       (9,889)
Deferred compensation plan 2         2     2
Net cash distributed to noncontrolling interest               (3,608) (3,608)
Balance at Jun. 30, 2021 2,470,281 $ 812 1,302,439 7,093 1,159,304 754 $ (121) 26,095 2,496,376
Balance (in shares) at Jun. 30, 2021   81,153         6    
Balance at Dec. 31, 2021 2,522,668 $ 790 1,274,446 (10,219) 1,257,014 752 $ (115) 26,535 2,549,203
Balance (in shares) at Dec. 31, 2021   78,965         6    
Increase (Decrease) in Stockholders' Equity                  
Net income 55,510       55,510     3,952 59,462
Other comprehensive income (loss) (85,060)     (85,060)         (85,060)
Stock-based compensation expense 7,219   7,219           7,219
Common stock issued to board members 305   305           305
Common stock issued to board members (in shares)   11              
Issuance of common stock related to share-based awards, net (4,066) $ 4 (4,070)           (4,066)
Issuance of common stock related to share-based awards, net (in shares)   469              
Repurchases of common stock (442,336) $ (148) (238,639)   (203,549)       (442,336)
Repurchases of common stock (in shares)   (14,869)              
Dividends on common stock (23,767)       (23,767)       (23,767)
Deferred compensation plan (896)         (57) $ (839)   (896)
Deferred compensation plan (in shares)             28    
Net cash distributed to noncontrolling interest               (2,661) (2,661)
Balance at Jun. 30, 2022 2,029,577 $ 646 1,039,261 (95,279) 1,085,208 695 $ (954) 27,826 2,057,403
Balance (in shares) at Jun. 30, 2022   64,576         34    
Balance at Mar. 31, 2022 2,463,933 $ 794 1,275,649 (80,565) 1,267,415 744 $ (104) 26,662 2,490,595
Balance (in shares) at Mar. 31, 2022   79,439         5    
Increase (Decrease) in Stockholders' Equity                  
Net income 33,260       33,260     2,063 35,323
Other comprehensive income (loss) (14,714)     (14,714)         (14,714)
Stock-based compensation expense 2,105   2,105           2,105
Common stock issued to board members 153   153           153
Common stock issued to board members (in shares)   6              
Issuance of common stock related to share-based awards, net (7)   (7)           (7)
Repurchases of common stock (442,336) $ (148) (238,639)   (203,549)       (442,336)
Repurchases of common stock (in shares)   (14,869)              
Dividends on common stock (11,918)       (11,918)       (11,918)
Deferred compensation plan (899)         (49) $ (850)   (899)
Deferred compensation plan (in shares)             29    
Net cash distributed to noncontrolling interest               (899) (899)
Balance at Jun. 30, 2022 $ 2,029,577 $ 646 $ 1,039,261 $ (95,279) $ 1,085,208 $ 695 $ (954) $ 27,826 $ 2,057,403
Balance (in shares) at Jun. 30, 2022   64,576         34